ZA200701139B - Fused tricyclic derivatives for the treatment of psychotic disorders - Google Patents

Fused tricyclic derivatives for the treatment of psychotic disorders

Info

Publication number
ZA200701139B
ZA200701139B ZA200701139A ZA200701139A ZA200701139B ZA 200701139 B ZA200701139 B ZA 200701139B ZA 200701139 A ZA200701139 A ZA 200701139A ZA 200701139 A ZA200701139 A ZA 200701139A ZA 200701139 B ZA200701139 B ZA 200701139B
Authority
ZA
South Africa
Prior art keywords
treatment
psychotic disorders
fused tricyclic
tricyclic derivatives
derivatives
Prior art date
Application number
ZA200701139A
Inventor
Bentley Jonathan
Bergauer Markus
Bertani Barbara
Biagetti Matteo
Borriello Manuela
Bromidge Steven Mark
Massimo Gianotti
Granci Enrica
Leslie Colin Philip
Pasquarello Alessandra
Zucchelli Valeria
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA200701139B publication Critical patent/ZA200701139B/en

Links

ZA200701139A 2004-08-31 2007-02-08 Fused tricyclic derivatives for the treatment of psychotic disorders ZA200701139B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0419315A GB0419315D0 (en) 2004-08-31 2004-08-31 Compounds

Publications (1)

Publication Number Publication Date
ZA200701139B true ZA200701139B (en) 2008-08-27

Family

ID=33104846

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701139A ZA200701139B (en) 2004-08-31 2007-02-08 Fused tricyclic derivatives for the treatment of psychotic disorders

Country Status (2)

Country Link
GB (1) GB0419315D0 (en)
ZA (1) ZA200701139B (en)

Also Published As

Publication number Publication date
GB0419315D0 (en) 2004-09-29

Similar Documents

Publication Publication Date Title
IL181387A0 (en) Fused tricyclic derivatives for the treatment of psychotic disorders
ZA200801888B (en) Derivatives of 4-piperazin-1-1-YL-4-benzo [B] thiophene suitable for the treatment of CNS disorders
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
EG25204A (en) Benzo diazepine derivatives for the treatment of neurological disorders
IL180680A0 (en) Piperazine derivatives useful for the treatment of gastrointestinal disorders
ZA200700384B (en) Hydantoin derivatives for the treatment of inflammatory disorders
EP1853539A4 (en) Honokiol derivatives for the treatment of proliferative disorders
IL178648A0 (en) Substituted morpholine compounds for the treatment of central nervous system disorders
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
PT1833799E (en) 3-phenyl-pyrazole derivatives as modulators of the 5-ht-2a serotonin receptor useful for the treatment of disorders related thereto
HK1096083A1 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
ZA200703244B (en) Halogen substituted benzodiazepine derivatives
PL1907374T3 (en) Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders
PL1685125T3 (en) Pyrrole derivatives useful for the treatment of proliferative diseases
PL1727545T3 (en) Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies
PL1904060T3 (en) Use of phthalocyanine derivates for the non-photodynamic treatment of diseases
TWI340643B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
ZA200701139B (en) Fused tricyclic derivatives for the treatment of psychotic disorders
ZA200703885B (en) 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
HUP0501046A2 (en) Process for the preparation of olanzapine
IL175611A0 (en) Combinations for the treatment of proliferative diseases
GB0408297D0 (en) Indole derivatives for the treatment of diseases